- Gilead’s new pricing starts to pop the gross-to-net bubble
- New fact-based insights on patient out-of-pocket costs and prescription abandonment
- Cool new stats on hospital-physician vertical integration by specialty
- The U.S. healthcare crisis will probably never end (Sorry.)
P.S. Follow my daily stream of links to neat stuff at @DrugChannels on Twitter.Recent tweets have highlighted rebates, step therapy, PSAOs, white bagging, PBM network spreads, lab-based microbreweries, and more.